Facile "stop codon" method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers

Biochemical and Biophysical Research Communications

Volumn 443, Issue 3, 2014, Pages 1085-1091

  Ha, Yonghwang ^a   Yang, Aerin ^a   Lee, Seyoung ^a   Kim, Kibong ^a   Liew, Hyunjeong ^b   Suh, Yoo Hun ^c,d   Park, Hee Sung ^a   Churchill, David G ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul National University   (South Korea)

^d Korea Brain Research Institute (KBRI)   (South Korea)

Author keywords

Copper; Dopamine; Oligomerization; Phosphorylation; Pyridoxal 5 phosphate; Stop codon

Indexed keywords

ALPHA SYNUCLEIN; COPPER; DOPAMINE; PHOSPHOSERINE; PYRIDOXAL 5 PHOSPHATE; SERINE;

ANALYTIC METHOD; ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; CYTOTOXICITY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; NERVE CELL; NEUROBLASTOMA CELL; NEURONAL TOXICITY; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; STOP CODON; STOP CODON METHOD; TANDEM MASS SPECTROMETRY; WST-1 ASSAY;

COPPER; DOPAMINE; OLIGOMERIZATION; PHOSPHORYLATION; PYRIDOXAL 5′-PHOSPHATE; STOP CODON;

ALPHA-SYNUCLEIN; CELL LINE; CODON, TERMINATOR; COPPER; DOPAMINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; NEURONS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN MULTIMERIZATION; PYRIDOXAL PHOSPHATE;

EID: 84893697183     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.099     Document Type: Article

References (28)

1. H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah, M.S. Goldberg, J. Shen, K. Takio, and T. Iwatsubo Alpha-synuclein is phosphorylated in synucleinopathy lesions Nat. Cell Biol. 4 2002 160 164
2. M.G. Spillantini, M.L. Schmidt, V.M.Y. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
3. W.W. Smith, R.L. Margolis, X.J. Li, J.C. Troncoso, M.K. Lee, V.L. Dawson, T.M. Dawson, T. Iwatsubo, and C.A. Ross Alpha-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells J. Neurosci. 25 2005 5544 5552
4. K.Y. Chau, H.L. Ching, A.H.V. Schapira, and J.M. Cooper Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis J. Neurochem. 110 2009 1005 1013
5. C.L. Kragh, L.B. Lund, F. Febbraro, H.D. Hansen, W.P. Gai, O. El-Agnaf, C. Richter-Landsberg, and P.H. Jensen Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells J. Biol. Chem. 284 2009 10211 10222
6. L. Chen, and M.B. Feany Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease Nat. Neurosci. 8 2005 657 663
7. M. Bisaglia, S. Mammi, and L. Bubacco Kinetic and structural analysis of the early oxidation products of dopamine - analysis of the interactions with alpha-synuclein J. Biol. Chem. 282 2007 15597 15605
8. R. Cappai, S.L. Leck, D.J. Tew, N.A. Williamson, D.P. Smith, D. Galatis, R.A. Sharples, C.C. Curtain, F.E. Ali, R.A. Cherny, J.G. Culvenor, S.P. Bottomley, C.L. Masters, K.J. Barnham, and A.F. Hill Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J. 19 2005 1377 1379
9. J.A. Wright, X.Y. Wang, and D.R. Brown Unique copper-induced oligomers mediate alpha-synuclein toxicity FASEB J. 23 2009 2384 2393
10. K. Vekrellis, and L. Stefanis Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies Expert Opin. Ther. Targets 16 2012 421 432
11. M.R. Sierks, G. Chatterjee, C. McGraw, S. Kasturirangan, P. Schulz, and S. Prasad CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease Integr. Biol. 3 2011 1188 1196
12. P.G. Foulds, J.D. Mitchell, A. Parker, R. Turner, G. Green, P. Diggle, M. Hasegawa, M. Taylor, D. Mann, and D. Allsop Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease FASEB J. 25 2011 4127 4137
13. S.S. Bharathi, and K.S.J. Indi Rao, Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study Neurosci. Lett. 424 2007 78 82
14. J.M. Berg, J.L. Tymoczko, and L. Stryer Biochemistry fifth ed. 2001 W.H. Freeman and Company New York
15. Y. Ha, H. Liew, H.Y. Park, K. Kim, Y.-H. Suh, and D.G. Churchill Interplay of salicylaldehyde, lysine, and M2+ ions on alpha-synuclein aggregation: cancellation of aggregation effects and determination of salicylaldehyde neurotoxicity Neurosci. Res. 71 2011 168 177
16. P.C. Burcham, L.M. Kaminskas, F.R. Fontaine, D.R. Petersen, and S.M. Pyke Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products Toxicology 181 2002 229 236
17. K.E. Paleologou, A. Oueslati, G. Shakked, C.C. Rospigliosi, H.Y. Kim, G.R. Lamberto, C.O. Fernandez, A. Schmid, F. Chegini, W.P. Gai, D. Chiappe, M. Moniatte, B.L. Schneider, P. Aebischer, D. Eliezer, M. Zweckstetter, E. Masliah, and H.A. Lashuel Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions J. Neurosci. 30 2010 3184 3198
18. J.P. Anderson, D.E. Walker, J.M. Goldstein, R. de Laat, K. Banducci, R.J. Caccavello, R. Barbour, J.P. Huang, K. Kling, M. Lee, L. Diep, P.S. Keim, X.F. Shen, T. Chataway, M.G. Schlossmacher, P. Seubert, D. Schenk, S. Sinha, W.P. Gai, and T.J. Chilcote Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease J. Biol. Chem. 281 2006 29739 29752
19. M. Hejjaoui, S. Butterfield, B. Fauvet, F. Vercruysse, J. Cui, I. Dikiy, M. Prudent, D. Olschewski, Y. Zhang, D. Eliezer, and H.A. Lashuel Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: alpha-synuclein phosphorylation at Tyrosine 125 J. Am. Chem. Soc. 134 2012 5196 5210
20. B. Fauvet, S.M. Butterfield, J. Fuks, A. Brik, and H.A. Lashuel One-pot total chemical synthesis of human α-synuclein Chem. Commun. 49 2013 9254 9256
21. H.-S. Park, M.J. Hohn, T. Umehara, L.-T. Guo, E.M. Osborne, J. Benner, C.J. Noren, J. Rinehart, and D. Soll Expanding the genetic code of Escherichia coli with phosphoserine Science 333 2011 1151 1154
22. S. Lee, S. Oh, A. Yang, J. Kim, D. Soll, D. Lee, and H.S. Park A facile strategy for selective incorporation of phosphoserine into histones Angew. Chem., Int. Ed. 52 2013 5771 5775
23. M. Mann, S.E. Ong, M. Gronborg, H. Steen, O.N. Jensen, and A. Pandey Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome Trends Biotechnol. 20 2002 261 268
24. S. Remani, J.K. Sun, R. Kotaria, J.A. Mayor, J.M. Brownlee, D.H.T. Harrison, D.E. Walters, and R.S. Kaplan The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate J. Bioenerg. Biomembr. 40 2008 577 585
25. E. Angot, J.A. Steiner, C. Hansen, J.Y. Li, and P. Brundin Are synucleinopathies prion-like disorders? Lancet Neurol. 9 2010 1128 1138
26. B.D. van Rooijen, M.M.A.E. Claessens, and V. Subramaniam Membrane permeabilization by oligomeric alpha-synuclein: in search of the mechanism PLoS One 5 2010 e14292 10.1371/journal.pone.0014292
27. M.J. Volles, S.J. Lee, J.C. Rochet, M.D. Shtilerman, T.T. Ding, J.C. Kessler, and P.T. Lansbury Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease Biochemistry 40 2001 7812 7819
28. J.N. Rees, V.R. Florang, L.L. Eckert, and J.A. Doorn Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol Chem. Res. Toxicol. 22 2009 1256 1263